Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diseases of the Colon & Rectum
Published in: Diseases of the Colon & Rectum 12/2005

01-12-2005 | Original Contribution

Gene Expression Profiling of Nonneoplastic Mucosa May Predict Clinical Outcome of Colon Cancer Patients

Authors: Alain Barrier, M.D., Pierre-Yves Boelle, Ph.D., Antoinette Lemoine, Ph.D., Chantal Tse, Ph.D., Didier Brault, Ph.D., Franck Chiappini, Ph.D., François Lacaine, M.D., Sidney Houry, M.D., Michel Huguier, M.D., Antoine Flahault, M.D., Ph.D., Sandrine Dudoit, Ph.D.

Published in: Diseases of the Colon & Rectum | Issue 12/2005

Login to get access

PURPOSE

This study assessed the possibility to build a prognosis predictor, based on microarray gene expression measures, in Stage II and III colon cancer patients.

METHODS

Tumor and nonneoplastic mucosa mRNA samples from 12 colon cancer patients were profiled using the Affymetrix HGU133A GeneChip. Six of 12 patients experienced a metachronous metastasis, whereas the 6 others remained disease-free for more than five years. Three datasets were constituted, including, respectively, the gene expression measures in tumor samples (T), in adjacent nonneoplastic mucosa samples (A), and the log-ratio of the gene expression measures (L). The step-down procedure of Westfall and Young and the k-nearest neighbor class prediction method were applied on T, A, and L. Leave-one-out cross-validation was used to estimate the generalization error of predictors based on different numbers of genes and neighbors.

RESULTS

The most frequent results were one false prediction with the A-based predictors (95 percent) and two false predictions with the T- and l-based predictors (65 and 60 percent, respectively). A-based predictors were more stable (i.e., less sensitive to changes of parameters, such as numbers of genes and neighbors) than T- and l-based predictors. Informative genes in A-based predictors included genes involved in the oxidative and phosphorylative mitochondrial metabolism and genes involved in cell-signaling pathways and their receptors.

CONCLUSIONS

This study suggests that one can build a prognosis predictor for Stage II and III colon cancer patients, based on microarray gene expression measures, and suggests the potential usefulness of nonneoplastic mucosa for this purpose.
Literature
1.
Fleming ID, Cooper JS, Henson DE, et al. AJCC: cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven, 1997
2.
Moertel, CG, Fleming, TR, MacDonald, JS,  et al. 1990Levamisole and fluorouracil as adjuvant therapy of resected colon carcinomaN Engl J Med3223528PubMedCrossRef
3.
Wolmark, N, Rockette, H, Fisher, B,  et al. 1993The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03J Clin Oncol11187987PubMed
4.
International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345:939–44.
5.
O'Connell, MJ, Mailliard, JA, Kahn, MJ,  et al. 1997Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancerJ Clin Oncol1524650PubMed
6.
Wolmark, N, Rockette, H, Mamounas, E,  et al. 1999Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon. Results from National Surgical Adjuvant Breast and Bowel Project C-04J Clin Oncol1735539PubMed
7.
O'Connell, MJ, Laurie, JA, Kahn, M,  et al. 1998Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancerJ Clin Oncol16295300PubMed
8.
Moore, HC, Haller, DG 1999Adjuvant therapy of colon cancerSemin Oncol2654555PubMed
9.
Zaniboni, A 1997Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survivalJ Clin Oncol15243241PubMed
10.
Andre, T, Boni, C, Mounedji-Boudiaf, L,  et al. 2004Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerN Engl J Med350234351PubMedCrossRef
11.
International Multicenter Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 1999;17:1356-63
12.
Mamounas, E, Wieand, S, Wolmark, N,  et al. 1999Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer. Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)J Clin Oncol17134955PubMed
13.
Gill, S, Loprinzi, CL, Sargent, DJ,  et al. 2004Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?J Clin Oncol221797806PubMedCrossRef
14.
Halling, KC, French, AJ, McDonnell, SK,  et al. 1999Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancersJ Natl Cancer Inst911295303PubMedCrossRef
15.
Gryfe, R, Kim, H, Hsieh, ET,  et al. 2000Tumor satellite instability and clinical outcome in young patients with colorectal cancerN Engl J Med3426977PubMedCrossRef
16.
Hawkins, N, Norrie, M, Cheong, K,  et al. 2002CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instabilityGastroenterology122137687PubMedCrossRef
17.
Wang, C, Rijnsoever, M, Grieu, F,  et al. 2003Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancerOncology6425965PubMedCrossRef
18.
Witzig, TE, Loprinzi, CL, Gonchoroff, NJ,  et al. 1991DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinomaCancer6887988PubMedCrossRef
19.
Chapman, MA, Hardcastle, JD, Armitage, NC 1995Five-year prospective study of DNA tumor ploidy and colorectal cancer survivalCancer763837PubMedCrossRef
20.
Martinez-Lopez, E, Abad, A, Font, A,  et al. 1998Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancerGastroenterology11411807PubMedCrossRef
21.
Zhou, W, Goodman, SN, Galizia, G,  et al. 2002Counting alleles to predict recurrence of early-stage colorectal cancersLancet35921925PubMedCrossRef
22.
McLeod, HL, Murray, GI 1999Tumor markers of prognosis in colorectal cancerBr J Cancer79191203PubMed
23.
Shibata, D, Reale, MA, Lavin, P,  et al. 1996The DCC protein and prognosis in colorectal cancerN Engl J Med335172732PubMedCrossRef
24.
Ogunbiyi, OA, Goodfellow, PJ, Herfarth, K,  et al. 1998Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicatorJ Clin Oncol1642733PubMed
25.
Sun, XF, Rutten, S, Zhang, H,  et al. 1999Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinomaJ Clin Oncol17174550PubMed
26.
Zhou, W, Galizia, G, Lieto, E,  et al. 2001Counting alleles reveals a connection between chromosome 18q loss and vascular invasionNat Biotechnol197881PubMedCrossRef
27.
Vant Veer, LJ, Dai, H, Vijver, MJ,  et al. 2002Gene expression profiling predicts clinical outcome of breast cancerNature4155306CrossRef
28.
Vijver, MJ, Yudong, DH, Vant Veer, LJ,  et al. 2002A gene-expression signature as a predictor of survival in breast cancerN Engl J Med34719992009PubMedCrossRef
29.
Beer, DG, Kardia, SLR, Huang, C,  et al. 2002Gene expression profiles predict survival of patients with lung adenocarcinomaNat Med881624PubMed
30.
Bhattacharjee, A, Richards, WG, Staunton, J,  et al. 2001Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclassesProc Natl Acad Sci USA98137905PubMedCrossRef
31.
Shipp, MA, Ross, KN, Tamayo, P,  et al. 2002Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learningNat Med86874PubMedCrossRef
32.
Rosenwald, A, Wright, G, Chan, WC,  et al. 2002The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphomaN Engl J Med346193747PubMedCrossRef
33.
Fredericksen, CM, Knudsen, S, Laurberg, S, Orntoft, TF 2003Classification of Dukes' B and C colorectal cancers using expression arraysJ Cancer Res Clin Oncol12926371
34.
Birkenkamp-Demtroder, K, Christensen, LL, Olesen, SH,  et al. 2002Gene expression in colorectal cancerCancer Res62435263PubMed
35.
Bertucci, F, Salas, S, Eysterier, S,  et al. 2004Gene expression profiling of colon cancer and correlation with histoclinical parametersOncogene23137791PubMedCrossRef
36.
37.
Alon, U, Barkai, N, Notterman, DA,  et al. 1999Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arraysProc Natl Acad Sci USA96674550PubMedCrossRef
38.
Backert, S, Gelos, M, Kobalz, U,  et al. 1999Differential gene expression in colon carcinoma cells and tissues detected with a cDNA arrayInt J Cancer8286874PubMedCrossRef
39.
Hedge, P, Qi, R, Gaspard, R,  et al. 2001Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarrayCancer Res6177927
40.
Kitahara, O, Furukawa, Y, Tanaka, T,  et al. 2001Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epitheliaCancer Res6135449PubMed
41.
Notterman, DA, Alon, U, Sierk, AJ, Levine, AJ 2001Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma and normal tissue examined by oligonucleotide arraysCancer Res61312430PubMed
42.
Agrawal, D, Chen, T, Irby, R,  et al. 2002Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profilingJ Natl Cancer Inst9451321PubMed
43.
Lin, YM, Furukawa, Y, Tsunoda, T, Yue, CT, Yang, KC, Nakamura, Y 2002Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomasOncogene2141208PubMedCrossRef
44.
Zou, TT, Selaru, FM, Xu, Y,  et al. 2002Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colonOncogene21485562PubMedCrossRef
45.
Tureci, O, Ding, J, Hilton, H,  et al. 2003Computational dissection of tissue contamination for identification of colon cancer-specific expression profilesFASEB J1737685PubMedCrossRef
46.
Williams, NS, Gaynor, RB, Scoggin, S,  et al. 2003Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interferenceClin Cancer Res993146PubMed
47.
Wang, Y, Jatkoe, T, Zhang, Y,  et al. 2004Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancerJ Clin Oncol27156471CrossRef
48.
Irizarry, RA, Hobbs, B, Collin, F,  et al. 2003Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics424964PubMedCrossRef
49.
Bolstad, BM, Irizarry, RA, Astrand, M, Speed, TP 2003A comparison of normalization methods for high density oligonucleotide array based on variance and biasBioinformatics1918593PubMedCrossRef
50.
Westfall PH, Young SS. Resampling-based multiple testing: examples and methods for p-value adjustment. New York: John Wiley £ Sons, 1993
51.
Laan, MJ, Dudoit, S, Pollard, KS 2004Multiple testing. Part II. Step-down procedures for control of the family-wise error rateStat Appl Genet Mol Biol314
52.
Dudoit, S, Shaffer, JP, Boldrick, JC 2003Multiple hypothesis testing in microarray experimentsStat Sci1871103CrossRef
53.
Dudoit S, Fridlyand J. Classification in microarray experiments. In: Speed T, ed. Statistical analysis of gene expression microarray data. Boca Raton: Chapman £ Hall/CRC, 2003:93–158
54.
Breiman, L 1996Heuristics of instability and stabilization in model selectionAnn Stat24235083CrossRef
55.
West, M, Blanchette, C, Dressman, H,  et al. 2001Predicting the clinical status of human breast cancer by using gene expression profilesProc Natl Acad Sci USA98114627PubMedCrossRef
56.
Ambroise, C, McLachlan, GJ 2002Selection bias in gene extraction on the basis of microarray gene-expression dataProc Natl Acad Sci USA9965626PubMedCrossRef
57.
Mueller, MM, Fusenig, NE 2004Friends or foes—bipolar effects of the tumour stroma in cancerNat Rev Cancer483949PubMedCrossRef
58.
Sternlicht, MD, Lochter, A, Sympson, CJ,  et al. 1999The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesisCell9813746PubMedCrossRef
59.
Bhowmick, NA, Chytil, A, Plieth, D,  et al. 2004TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epitheliaScience30384851PubMedCrossRef
60.
Chen, LC, Hao, CY, Chiu, YS,  et al. 2004Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patientsCancer Res643694700PubMedCrossRef
Metadata
Title
Gene Expression Profiling of Nonneoplastic Mucosa May Predict Clinical Outcome of Colon Cancer Patients
Authors
Alain Barrier, M.D.
Pierre-Yves Boelle, Ph.D.
Antoinette Lemoine, Ph.D.
Chantal Tse, Ph.D.
Didier Brault, Ph.D.
Franck Chiappini, Ph.D.
François Lacaine, M.D.
Sidney Houry, M.D.
Michel Huguier, M.D.
Antoine Flahault, M.D., Ph.D.
Sandrine Dudoit, Ph.D.
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 12/2005
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-005-0175-9

Other articles of this Issue 12/2005

Diseases of the Colon & Rectum 12/2005 Go to the issue

Original Contribution

Improvement of Wound Healing After Hemorrhoidectomy: A Double-Blind, Randomized Study of Botulinum Toxin Injection

Case Report

Phlebosclerotic Colitis With Deep Circumferential Ulceration: Three-Year Endoscopic Follow-Up. Report of a Case

OriginalPaper

Selected Abstracts

Original Contribution

Total Mesorectal Excision for Rectal Cancer: Difference in Outcome for Low and High Rectal Cancer

Case Report

Pinealoblastoma in a Patient With Familial Adenomatous Polyposis: Variant of Turcot Syndrome Type 2? Report of a Case and Review of the Literature

Letter to the Editor

Treatment of Pilonidal Sinus Disease Using Fibrin Glue